Comvita Limited Stocks

NZ$ 0.54Last Updated 08.01.2026

Issuer Rating

3/7

Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

NZ$ 20.59M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NZ$ 0.54
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Comvita Limited, together with its subsidiaries, engages in manufacturing and marketing natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney and skincare, gourmet honey, elixirs and lozenges, and cider vinegar products, as well as...

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is underpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of CVT.NZ is 0.80 and suggests 57% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks